UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice

Nature biotechnology, 2003-04, Vol.21 (4), p.387-391

2003

Volltextzugriff (PDF)

Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin

Blood, 2001-03, Vol.97 (5), p.1392-1398

2001

Volltextzugriff (PDF)

Targeting Multiple Her-2 Epitopes with Monoclonal Antibodies Results in Improved Antigrowth Activity of a Human Breast Cancer Cell Line in Vitro and in Vivo

Clinical cancer research, 2002-06, Vol.8 (6), p.1720-1730

2002

Volltextzugriff (PDF)

Disseminated or localized growth of a human B‐cell tumor (Daudi) in scid mice

International journal of cancer, 1990-03, Vol.45 (3), p.481-485

1990

Volltextzugriff (PDF)

Homodimerization of Tumor-Reactive Monoclonal Antibodies Markedly Increases their Ability to Induce Growth Arrest or Apoptosis of Tumor Cells

Proceedings of the National Academy of Sciences - PNAS, 1997-07, Vol.94 (14), p.7509-7514

1997

Volltextzugriff (PDF)

The Evaluation of Recombinant, Chimeric, Tetravalent Antihuman CD22 Antibodies

Clinical cancer research, 2004-02, Vol.10 (4), p.1274-1281

2004

Volltextzugriff (PDF)

Ricin A-Chain and Ricin A-Chain Immunotoxins Rapidly Damage Human Endothelial Cells: Implications for Vascular Leak Syndrome

Experimental cell research, 1993-06, Vol.206 (2), p.227-234

1993

Volltextzugriff (PDF)

The Antitumor Activity of an Anti-CD22 Immunotoxin in SCID Mice With Disseminated Daudi Lymphoma Is Enhanced by Either an Anti-CD19 Antibody or an Anti-CD19 Immunotoxin

Blood, 1992-11, Vol.80 (9), p.2315-2320

1992

Volltextzugriff (PDF)

The Combined Use of an Immunotoxin and a Radioimmunoconjugate to Treat Disseminated Human B-Cell Lymphoma in Immunodeficient Mice

Clinical cancer research, 2000-02, Vol.6 (2), p.631-642

2000

Volltextzugriff (PDF)

Immunotoxins for the treatment of B-cell lymphomas

Molecular medicine (Cambridge, Mass.), 1997-07, Vol.3 (7), p.420-427

1997

Volltextzugriff (PDF)

Recent developments in immunotoxin therapy

Current opinion in immunology, 1994, Vol.6 (5), p.707-714

1994

Volltextzugriff (PDF)

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest

Blood, 1994-03, Vol.83 (5), p.1329-1336

1994

Volltextzugriff (PDF)

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail

Blood, 1994-08, Vol.84 (3), p.702-707

1994

Volltextzugriff (PDF)

Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphoma

International journal of cancer, 1996-09, Vol.68 (1), p.93-96

1996

Volltextzugriff (PDF)

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail

Blood, 1994-08, Vol.84 (3), p.702-707

1994

Volltextzugriff (PDF)

The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond

Journal of immunological methods, 1991-09, Vol.142 (2), p.223-230

1991

Volltextzugriff (PDF)

Large scale preparation of immunotoxins constructed with the Fab′ fragment of IgG1 murine monoclonal antibodies and chemically deglycosylated ricin A chain

Journal of immunological methods, 1988-09, Vol.112 (2), p.267-277

1988

Volltextzugriff (PDF)

Large scale preparation of an immunoconjugate constructed with human recombinant CD4 and deglycosylated ricin A chain

Journal of immunological methods, 1990-01, Vol.126 (1), p.135-141

1990

Volltextzugriff (PDF)

Covalent binding of human alpha 2-macroglobulin to deglycosylated ricin A chain and its immunotoxins

Cancer research (Chicago, Ill.), 1991-03, Vol.51 (5), p.1482

1991

Volltextzugriff (PDF)

Interaction between rabbit IgG immune complexes and Ricinus agglutinin

Journal of immunological methods, 1986-03, Vol.87 (2), p.239-244

1986

Volltextzugriff (PDF)

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin

Blood, 1992-11, Vol.80 (9), p.2315-2320

1992

Volltextzugriff (PDF)

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest

Blood, 1994-03, Vol.83 (5), p.1329-1336

1994

Volltextzugriff (PDF)

Effect of sublethal irradiation of SCID mice on growth of B-cell lymphoma xenografts and on efficacy of chemotherapy and/or immunotoxin therapy

Laboratory animal science (Chicago), 1996-06, Vol.46 (3), p.305

1996

Volltextzugriff (PDF)

Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

Clinical and experimental rheumatology, 2024-02

2024

Volltextzugriff (PDF)

HIV-Infected Cells are Killed by rCD4-Ricin A Chain

Science (American Association for the Advancement of Science), 1988-11, Vol.242 (4882), p.1166-1168

1988

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(37)

Sprache

Englisch
(32)
Französisch
(6)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice

Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin

Targeting Multiple Her-2 Epitopes with Monoclonal Antibodies Results in Improved Antigrowth Activity of a Human Breast Cancer Cell Line in Vitro and in Vivo

Disseminated or localized growth of a human B‐cell tumor (Daudi) in scid mice

Homodimerization of Tumor-Reactive Monoclonal Antibodies Markedly Increases their Ability to Induce Growth Arrest or Apoptosis of Tumor Cells

The Evaluation of Recombinant, Chimeric, Tetravalent Antihuman CD22 Antibodies

Ricin A-Chain and Ricin A-Chain Immunotoxins Rapidly Damage Human Endothelial Cells: Implications for Vascular Leak Syndrome

The Antitumor Activity of an Anti-CD22 Immunotoxin in SCID Mice With Disseminated Daudi Lymphoma Is Enhanced by Either an Anti-CD19 Antibody or an Anti-CD19 Immunotoxin

The Combined Use of an Immunotoxin and a Radioimmunoconjugate to Treat Disseminated Human B-Cell Lymphoma in Immunodeficient Mice

Immunotoxins for the treatment of B-cell lymphomas

Recent developments in immunotoxin therapy

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail

Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphoma

Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail

The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond

Large scale preparation of immunotoxins constructed with the Fab′ fragment of IgG1 murine monoclonal antibodies and chemically deglycosylated ricin A chain

Large scale preparation of an immunoconjugate constructed with human recombinant CD4 and deglycosylated ricin A chain

Covalent binding of human alpha 2-macroglobulin to deglycosylated ricin A chain and its immunotoxins

Interaction between rabbit IgG immune complexes and Ricinus agglutinin

The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin

Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest

Effect of sublethal irradiation of SCID mice on growth of B-cell lymphoma xenografts and on efficacy of chemotherapy and/or immunotoxin therapy

Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

HIV-Infected Cells are Killed by rCD4-Ricin A Chain

Suchergebnisse filtern